# Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.

> **NCT04440774** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 120 (actual)

## Conditions studied

- Chikungunya
- Zika

## Interventions

- **BIOLOGICAL:** CHIK low dose
- **BIOLOGICAL:** CHIK mid dose
- **BIOLOGICAL:** CHIK high dose
- **BIOLOGICAL:** ZIKA low dose
- **BIOLOGICAL:** ZIKA mid dose
- **BIOLOGICAL:** ZIKA high dose
- **BIOLOGICAL:** Saline placebo

## Key facts

- **NCT ID:** NCT04440774
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2022-02-18
- **Final completion:** 2022-02-18
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04440774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04440774, "Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04440774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*